Clinical trial
An Open-label, Randomized, Multi-center, Parallel-group Clinical Trial Comparing the Efficacy and Safety of Insulin RinGlar® ("Geropharm", Russia) Compared to Lantus® SoloStar® ("Sanofi-Aventis Deutschland GmbH", Germany) in Type 1 Diabetes Mellitus Patients
NCT04022993 is registered in ClinicalTrials.gov with Geropharm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Randomized, Multi-center, Parallel-group Clinical Trial Comparing the Efficacy and Safety of Insulin RinGlar® ("Geropharm", Russia) Compared to Lantus® SoloStar® ("Sanofi-Aventis Deutschland GmbH", Germany) in Type 1 Diabetes Mellitus Patients
- Lead sponsor
- Geropharm
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 4, 2018
- Completion date
- May 15, 2019
- Enrollment
- 180 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.